The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Thrombin (Human)-Global Market Insights and Sales Trends 2025

Thrombin (Human)-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1814109

No of Pages : 108

Ask Your Query
Synopsis
The global Thrombin (Human) market size is expected to reach US$ 704.7 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Thrombin (Human) in various end use industries. The expanding demands from the Biotechnology, Medicine, Microbiology and Others, are propelling Thrombin (Human) market. 500IU/Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 1000IU/Vial segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thrombin (Human), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thrombin (Human) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thrombin (Human) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thrombin (Human) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thrombin (Human) covered in this report include Baxter, AMRESCO Inc, BD Biosciences, Life Technologies Corporation, PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB, CSL and Bayer, etc.
The global Thrombin (Human) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
Global Thrombin (Human) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thrombin (Human) market, Segment by Type:
500IU/Vial
1000IU/Vial
2500IU/Vial
Global Thrombin (Human) market, by Application
Biotechnology
Medicine
Microbiology
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Thrombin (Human) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Thrombin (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Thrombin (Human) Market Overview
1.1 Thrombin (Human) Product Overview
1.2 Thrombin (Human) Market Segment by Type
1.2.1 500IU/Vial
1.2.2 1000IU/Vial
1.2.3 2500IU/Vial
1.3 Global Thrombin (Human) Market Size by Type
1.3.1 Global Thrombin (Human) Market Size Overview by Type (2018-2029)
1.3.2 Global Thrombin (Human) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Thrombin (Human) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Thrombin (Human) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Thrombin (Human) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Thrombin (Human) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Thrombin (Human) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Thrombin (Human) Sales Breakdown by Type (2018-2023)
2 Global Thrombin (Human) Market Competition by Company
2.1 Global Top Players by Thrombin (Human) Sales (2018-2023)
2.2 Global Top Players by Thrombin (Human) Revenue (2018-2023)
2.3 Global Top Players by Thrombin (Human) Price (2018-2023)
2.4 Global Top Manufacturers Thrombin (Human) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Thrombin (Human) Market Competitive Situation and Trends
2.5.1 Thrombin (Human) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Thrombin (Human) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thrombin (Human) as of 2022)
2.7 Date of Key Manufacturers Enter into Thrombin (Human) Market
2.8 Key Manufacturers Thrombin (Human) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Thrombin (Human) Status and Outlook by Region
3.1 Global Thrombin (Human) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Thrombin (Human) Historic Market Size by Region
3.2.1 Global Thrombin (Human) Sales in Volume by Region (2018-2023)
3.2.2 Global Thrombin (Human) Sales in Value by Region (2018-2023)
3.2.3 Global Thrombin (Human) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Thrombin (Human) Forecasted Market Size by Region
3.3.1 Global Thrombin (Human) Sales in Volume by Region (2024-2029)
3.3.2 Global Thrombin (Human) Sales in Value by Region (2024-2029)
3.3.3 Global Thrombin (Human) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Thrombin (Human) by Application
4.1 Thrombin (Human) Market Segment by Application
4.1.1 Biotechnology
4.1.2 Medicine
4.1.3 Microbiology
4.1.4 Others
4.2 Global Thrombin (Human) Market Size by Application
4.2.1 Global Thrombin (Human) Market Size Overview by Application (2018-2029)
4.2.2 Global Thrombin (Human) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Thrombin (Human) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Thrombin (Human) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Thrombin (Human) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Thrombin (Human) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Thrombin (Human) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Thrombin (Human) Sales Breakdown by Application (2018-2023)
5 North America Thrombin (Human) by Country
5.1 North America Thrombin (Human) Historic Market Size by Country
5.1.1 North America Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Thrombin (Human) Sales in Volume by Country (2018-2023)
5.1.3 North America Thrombin (Human) Sales in Value by Country (2018-2023)
5.2 North America Thrombin (Human) Forecasted Market Size by Country
5.2.1 North America Thrombin (Human) Sales in Volume by Country (2024-2029)
5.2.2 North America Thrombin (Human) Sales in Value by Country (2024-2029)
6 Europe Thrombin (Human) by Country
6.1 Europe Thrombin (Human) Historic Market Size by Country
6.1.1 Europe Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Thrombin (Human) Sales in Volume by Country (2018-2023)
6.1.3 Europe Thrombin (Human) Sales in Value by Country (2018-2023)
6.2 Europe Thrombin (Human) Forecasted Market Size by Country
6.2.1 Europe Thrombin (Human) Sales in Volume by Country (2024-2029)
6.2.2 Europe Thrombin (Human) Sales in Value by Country (2024-2029)
7 Asia-Pacific Thrombin (Human) by Region
7.1 Asia-Pacific Thrombin (Human) Historic Market Size by Region
7.1.1 Asia-Pacific Thrombin (Human) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Thrombin (Human) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Thrombin (Human) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Thrombin (Human) Forecasted Market Size by Region
7.2.1 Asia-Pacific Thrombin (Human) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Thrombin (Human) Sales in Value by Region (2024-2029)
8 Latin America Thrombin (Human) by Country
8.1 Latin America Thrombin (Human) Historic Market Size by Country
8.1.1 Latin America Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Thrombin (Human) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Thrombin (Human) Sales in Value by Country (2018-2023)
8.2 Latin America Thrombin (Human) Forecasted Market Size by Country
8.2.1 Latin America Thrombin (Human) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Thrombin (Human) Sales in Value by Country (2024-2029)
9 Middle East and Africa Thrombin (Human) by Country
9.1 Middle East and Africa Thrombin (Human) Historic Market Size by Country
9.1.1 Middle East and Africa Thrombin (Human) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Thrombin (Human) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Thrombin (Human) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Thrombin (Human) Forecasted Market Size by Country
9.2.1 Middle East and Africa Thrombin (Human) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Thrombin (Human) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Information
10.1.2 Baxter Introduction and Business Overview
10.1.3 Baxter Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Baxter Thrombin (Human) Products Offered
10.1.5 Baxter Recent Development
10.2 AMRESCO Inc
10.2.1 AMRESCO Inc Company Information
10.2.2 AMRESCO Inc Introduction and Business Overview
10.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AMRESCO Inc Thrombin (Human) Products Offered
10.2.5 AMRESCO Inc Recent Development
10.3 BD Biosciences
10.3.1 BD Biosciences Company Information
10.3.2 BD Biosciences Introduction and Business Overview
10.3.3 BD Biosciences Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BD Biosciences Thrombin (Human) Products Offered
10.3.5 BD Biosciences Recent Development
10.4 Life Technologies Corporation
10.4.1 Life Technologies Corporation Company Information
10.4.2 Life Technologies Corporation Introduction and Business Overview
10.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Life Technologies Corporation Thrombin (Human) Products Offered
10.4.5 Life Technologies Corporation Recent Development
10.5 PromoCell GmbH
10.5.1 PromoCell GmbH Company Information
10.5.2 PromoCell GmbH Introduction and Business Overview
10.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 PromoCell GmbH Thrombin (Human) Products Offered
10.5.5 PromoCell GmbH Recent Development
10.6 Sigma-Aldrich Corporation
10.6.1 Sigma-Aldrich Corporation Company Information
10.6.2 Sigma-Aldrich Corporation Introduction and Business Overview
10.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sigma-Aldrich Corporation Thrombin (Human) Products Offered
10.6.5 Sigma-Aldrich Corporation Recent Development
10.7 Vitrolife AB
10.7.1 Vitrolife AB Company Information
10.7.2 Vitrolife AB Introduction and Business Overview
10.7.3 Vitrolife AB Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Vitrolife AB Thrombin (Human) Products Offered
10.7.5 Vitrolife AB Recent Development
10.8 CSL
10.8.1 CSL Company Information
10.8.2 CSL Introduction and Business Overview
10.8.3 CSL Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 CSL Thrombin (Human) Products Offered
10.8.5 CSL Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bayer Thrombin (Human) Products Offered
10.9.5 Bayer Recent Development
10.10 Grifols
10.10.1 Grifols Company Information
10.10.2 Grifols Introduction and Business Overview
10.10.3 Grifols Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Grifols Thrombin (Human) Products Offered
10.10.5 Grifols Recent Development
10.11 Octapharma
10.11.1 Octapharma Company Information
10.11.2 Octapharma Introduction and Business Overview
10.11.3 Octapharma Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Octapharma Thrombin (Human) Products Offered
10.11.5 Octapharma Recent Development
10.12 Shanghai RAAS
10.12.1 Shanghai RAAS Company Information
10.12.2 Shanghai RAAS Introduction and Business Overview
10.12.3 Shanghai RAAS Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Shanghai RAAS Thrombin (Human) Products Offered
10.12.5 Shanghai RAAS Recent Development
10.13 Hualan Biological
10.13.1 Hualan Biological Company Information
10.13.2 Hualan Biological Introduction and Business Overview
10.13.3 Hualan Biological Thrombin (Human) Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Hualan Biological Thrombin (Human) Products Offered
10.13.5 Hualan Biological Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Thrombin (Human) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Thrombin (Human) Industrial Chain Analysis
11.4 Thrombin (Human) Market Dynamics
11.4.1 Thrombin (Human) Industry Trends
11.4.2 Thrombin (Human) Market Drivers
11.4.3 Thrombin (Human) Market Challenges
11.4.4 Thrombin (Human) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Thrombin (Human) Distributors
12.3 Thrombin (Human) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock